These dual-compound protocols provide flexible dosing of both GLP-1 agonists, allowing your provider to fine-tune your weight loss therapy without adding multiple injections or pills to your daily routine
It is undergoing clinical trials but is being sold in an unregulated manner
This method, primarily in the form of subcutaneous injections, ensures higher bioavailability and effectiveness
Mild and temporary side effects may include localized injection site irritation, transient water retention, or changes in appetite
Form & Analytical Testing AOD-9604 is supplied as a research-grade synthetic peptide material presented in lyophilized powder form
Bile duct injury Cholestatic and mixed liver injuries can damage the bile ducts, characterized by the destruction of the bile duct lining epithelium, potentially contributing to the progression of biliary cirrhosis